RPB5-Mediating Protein Promotes Cholangiocarcinoma Tumorigenesis and Drug Resistance by Competing With NRF2 for KEAP1 Binding.
Zheng-Hua WanTian-Yi JiangYuan-Yuan ShiYu-Fei PanYun-Kai LinYun-Han MaChun YangXiao-Fan FengLi-Feng HuangXiao-Ni KongZhi-Wen DingYe-Xiong TanLi-Wei DongHong-Yang WangPublished in: Hepatology (Baltimore, Md.) (2020)
These findings reveal that RMP is involved in the oxidative stress defense program and could be exploited for targeted cancer therapies.